A phase II study of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic or recurrent squamous cell cancer of the head and neck (SCCHN).
2010 ◽
Vol 28
(15_suppl)
◽
pp. 5532-5532
◽
Keyword(s):
Phase Ii
◽